These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 5960309)

  • 1. [Osmolarity and plasmatic tonicity and their regulation in chronic renal insufficiency].
    Cioni L; Balestri PL; Giovannetti S
    Minerva Nefrol; 1966; 13(2):55-8. PubMed ID: 5960309
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fibrinogen degradatiopnroducts in the serum and urine in chronic nephritis].
    Kutyrina IM; Muzychenko LI; Nevraeva OG; Kriachko AA; Tareeva IE
    Sov Med; 1978 Oct; (10):68-75. PubMed ID: 715539
    [No Abstract]   [Full Text] [Related]  

  • 3. Down-regulation of PTH/PTHrP receptor in the kidney of patients with renal impairment.
    Chen J; Zhang J; Lin S
    Chin Med J (Engl); 1998 Jan; 111(1):24-7. PubMed ID: 10322647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Calcium balance in chronic renal insufficiency].
    Graziani G; Della Grazia M; Imbasciati E; Ponticelli C; Redaelli B
    Minerva Nefrol; 1967; 14(3):125-9. PubMed ID: 5596513
    [No Abstract]   [Full Text] [Related]  

  • 5. [Analysis of the body distribution of calcium in patients with kidney diseases with and without renal insufficiency].
    Mioni G; D'Angelo A; Ossi E; Maschio G
    Minerva Nefrol; 1972; 19(3):157-64. PubMed ID: 4681088
    [No Abstract]   [Full Text] [Related]  

  • 6. [Albumin metabolism in chronic renal insufficiency].
    Kozlov VV; Rjabov SI
    Z Gesamte Inn Med; 1981 Nov; 36(22):889-91. PubMed ID: 7342514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paradoxic hypercalcemia and hypophosphatemia associated with chronic renal failure in horses.
    Tennant B; Bettleheim P; Kaneko JJ
    J Am Vet Med Assoc; 1982 Mar; 180(6):630-4. PubMed ID: 7068501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acid-base equilibrium and chronic renal insufficiency].
    Aznar Reig A; Palma Alvarez A; Fernández-Andrade C
    Rev Clin Esp; 1969 Jan; 112(1):43-56. PubMed ID: 5766957
    [No Abstract]   [Full Text] [Related]  

  • 9. [Diurnal rhythm of calcium- and magnesium excretion of kidney in health people and patients with primary chronic glomerular nephritis].
    Mel'man NIa
    Fiziol Zh; 1971; 17(2):247-50. PubMed ID: 5566000
    [No Abstract]   [Full Text] [Related]  

  • 10. [Heat exchange in children with chronic glomerulonephritis].
    Lipko MP
    Pediatr Akus Ginekol; 1973; 2():4-6. PubMed ID: 4790503
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolomic identification of potential phospholipid biomarkers for chronic glomerulonephritis by using high performance liquid chromatography-mass spectrometry.
    Jia L; Wang C; Zhao S; Lu X; Xu G
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Dec; 860(1):134-40. PubMed ID: 17996503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Active focal segmental glomerulosclerosis is associated with massive oxidation of plasma albumin.
    Musante L; Candiano G; Petretto A; Bruschi M; Dimasi N; Caridi G; Pavone B; Del Boccio P; Galliano M; Urbani A; Scolari F; Vincenti F; Ghiggeri GM
    J Am Soc Nephrol; 2007 Mar; 18(3):799-810. PubMed ID: 17287427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Care of chronic kidney patients. Possibilities and limits of prevention, treatment and rehabilitation in the clinical stage of chronic kidney insufficiency].
    Buchborn E
    Internist (Berl); 1983 Sep; 24(9):487-93. PubMed ID: 6354966
    [No Abstract]   [Full Text] [Related]  

  • 14. [Iron metabolism in bone marrow erythroid cells in chronic kidney failure].
    Broĭ-Karrĕ TA
    Klin Med (Mosk); 1982 Jan; 60(1):45-9. PubMed ID: 7078038
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical value of the determination of beta 2 microglobulin in kidney diseases].
    Potsybina VV; Baran EIa
    Urol Nefrol (Mosk); 1984; (3):53-6. PubMed ID: 6377647
    [No Abstract]   [Full Text] [Related]  

  • 16. Methods of cardio-renal protection in non-diabetic chronic nephropathies.
    Ruggenenti P; Remuzzi G
    Rocz Akad Med Bialymst; 2004; 49():116-23. PubMed ID: 15631326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relation between metabolism of trace elements and the antioxidant defense system in chronic nephropathies].
    Podracká L; Sasinka M; Rácz O; Sipulová A; Gayová E; Horská M; Boor A
    Cas Lek Cesk; 1999 May; 138(11):337-9. PubMed ID: 10422345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Current trends in the treatment of chronic glomerulonephritis].
    Belovezhdov N; Altŭnkova I; Neshev Kh; Robeva R; Gruev I
    Vutr Boles; 1981; 20(5):54-64. PubMed ID: 7324454
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanism f kidney participation in maintaining osmotic and ion homeostasis in chronic renal failure].
    Bogolepova AE; Kuznetsova AA; Lukichev BG; Natochkin IuV; Parshukova OIu; Prutskova NP; Shakhmatova EI
    Urologiia; 2000; (3):5-8. PubMed ID: 11186713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibody 1-22-3-induced glomerulonephritis in uninephrectomized rats as a model of progressive renal failure.
    Tomita M; Sogabe H; Nakazato S; Nakatsuji S; Noto T; Hamada K; Kawachi H; Shimizu F; Matsuo M; Mutoh S
    Nephrol Dial Transplant; 2005 Nov; 20(11):2358-67. PubMed ID: 16091375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.